Latest Shareholder Interests News

Kogan.com reported robust FY25 growth driven by its diversified business model, while Mighty Ape in New Zealand embarks on a recovery plan aiming for profitability in FY26. The group’s strong cash flow and governance upgrades underpin confidence in future expansion.

Golden State Mining has completed a $1.5 million placement at 0.8 cents per share, appointed Keith Middleton as Managing Director, and launched a strategic review of its gold projects in Western Australia.

Gladiator Resources has reaffirmed the binding nature of its agreement with Apex USA Resources LLC for Rare Earth Elements tenements in the US, despite ongoing disputes among Apex principals and ASX scrutiny.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

London City Equities and Excelsior Capital have settled their legal dispute, with Excelsior agreeing to a company-managed liquidation and delisting from the ASX by June 2026. This resolution avoids costly litigation and refocuses London City on its investment strategy.

QuickFee Limited reports a pivotal FY25 with strong revenue growth and positive underlying profitability, alongside a strategic sale of its US Pay Now business and a proposed capital return to shareholders.

Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.

The Takeovers Panel has intervened in the Mayne Pharma and Cosette Pharmaceuticals scheme, issuing interim orders that extend the deal deadline and restrict termination rights to maintain the status quo.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Clean TeQ Water has raised A$6 million through a placement supported by major shareholders to fund its expanding international water and resource recovery projects while strengthening its balance sheet.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.